Additional Details

  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    University of Virginia Health System
    Charlottesville VA. 22908
    View Details

  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

    Clinical Trials Center of Middle Tennessee, LLC
    Franklin TN. 37067
    View Details

  • Inspiratory Work of Breathing Before and After Extubation

    Toronto General Hospital, University Health Network
    Toronto ON. M5G2C4
    View Details

  • Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

    Weill Cornell Medicine
    New York NY. 10065
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Boston, MA
    Boston MA. 02114
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Louisville, KY
    Louisville KY. 40202
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Charleston, SC
    Charleston SC. 29425
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Salt Lake City, UT
    Salt Lake City UT. 84103
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Ann Arbor, MI
    Ann Arbor MI. 48209
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Nashville, TN
    Nashville TN. 37204
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Durham, NC
    Durham NC. 27710
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Denver, CO
    Denver CO. 80206
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Wilwaukee, WI
    Milwaukee WI. 52226
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Calgary, Alberta
    Calgary AB. T2N 4Z5
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Los Angeles, CA
    Los Angeles CA. 90033
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Birmingham, AL
    Birmingham AL. 35233
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Baltimore, MD
    Baltimore MD. 21224
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer Site in Detroit, MI
    Detroit MI. 48202
    View Details

  • WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

    WISPer site in Trois-Rivières, Quebec
    Trois-Rivières QC. G8T 7A1
    View Details